Hemolab 100mg/1.5mg Injection
Marketer
Laborate Pharmaceuticals India Ltd
Salt Composition
Ferrous Ascorbate (100mg) + Folic Acid (1.5mg)
Overview Hemolab 100mg/1.5mg Injection
Iron deficiency and anemia are treated with the combination drug, Hemolab Injection (100mg/1.5mg). This medication facilitates healthy cell production and replenishes blood iron stores. Administered intravenously under medical guidance, self-injection is strictly prohibited. Dosage frequency is condition-dependent, determined by your physician to optimize symptom improvement. Continue treatment as directed. Common side effects include nausea, vomiting, and gastrointestinal distress; report any concerning symptoms to your doctor for potential management strategies. Alcohol consumption is generally discouraged during treatment. Full disclosure of all concurrent medications is crucial, as interactions may compromise Hemolab's efficacy or alter its effects.
Uses of Hemolab 100mg/1.5mg Injection
Managing iron deficiency and anemia
Major Benefits of Hemolab 100mg/1.5mg Injection:
Administering this medication will be handled by your healthcare provider; please refrain from self-medication.
Common Side effects of Hemolab 100mg/1.5mg Injection:
- Nausea
- Vomiting
- Dark colored stool
- Upset stomach
How to use Hemolab 100mg/1.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Hemolab 100mg/1.5mg Injection works:
Hemolab Injection (100mg/1.5mg) combines Ferrous Ascorbate and Folic Acid to restore essential nutrients. Folic Acid, a B vitamin, is crucial for red blood cell production, vital for oxygen transport. Its role in fetal brain and spinal cord development makes it essential during pregnancy. Ferrous Ascorbate aids various bodily processes, enhancing oxygen utilization, cell growth, and red blood cell and hemoglobin synthesis.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Hemolab 100mg/1.5mg Injection is contraindicated.
PregnancySAFE IF PRESCRIBED
The injectable medication Hemolab 100mg/1.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely administer Hemolab 100mg/1.5mg Injection. Research in humans indicates negligible drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Hemolab 100mg/1.5mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Hemolab 100mg/1.5mg Injection in patients with kidney disease appears to be safe. Preliminary findings indicate that dose modification for Hemolab 100mg/1.5mg Injection might be unnecessary in such cases. However, medical advice is recommended.
LiverSAFE IF PRESCRIBED
In patients with liver impairment, Hemolab 100mg/1.5mg Injection appears to be well-tolerated. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Hemolab 100mg/1.5mg Injection :
Omit a Hemolab 100mg/1.5mg Injection dose? Seek medical advice immediately.
Facts to Know About Hemolab 100mg/1.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently